Endocrine diseases on Notably News

Endocrine diseases

Follow Endocrine diseases on Notably News to receive short updates to your email — rarely!

We include updates on Polycystic ovary syndrome, Postural orthostatic tachycardia syndrome, Diabetes, Hypothyroidism, Hashimoto's thyroiditis, Cushing's syndrome, Osteoporosis, Gynecomastia, Pervez Musharraf, Bob Casey Sr., Precocious puberty, Robert Jordan, Metabolic syndrome, Androgen insensitivity syndrome, Goitre, Matthew Garber ... and more.

2022	Diabetes Global diabetes diagnosis count dramatically increased to 830 million people, representing a more than fourfold increase from 1990 levels.
2022	Diabetes Diabetes diagnoses dramatically increased to 830 million people globally, far exceeding previous projections and representing approximately one in seven adults worldwide.
2022	Diabetes Diabetes diagnoses globally increase to 830 million people, dramatically exceeding previous projections and highlighting the disease's rapid global spread.
2022	Hyperandrogenism InterACT, an intersex organization, officially listed hyperandrogenism as an intersex variation in their glossary, helping to formally recognize and define the condition within intersex terminology.
2020	Diabetes A Cochrane systematic review was conducted comparing non-nutritive sweeteners to sugar, placebo, and a nutritive low-calorie sweetener, examining their effects on diabetes management parameters.
2020	Polycystic ovary syndrome A systematic review and meta-analysis of 5,366 women with PCOS was conducted, analyzing sexual dysfunction and testosterone levels, finding an average testosterone level of 2.34 nmol/L.
2019	Diabetes A systematic review found no evidence of additional benefit from blood pressure lowering to between 130-140 mmHg, while noting an increased risk of adverse events.
May 1 2019	Hyperandrogenism The International Association of Athletics Federations released the Eligibility Regulations for the Female Classification (Athletes with Differences of Sexual Development), which specifically addressed regulations for female athletes with differences in sex development (DSD) and high testosterone levels, narrowing the scope from previous hyperandrogenism regulations.
2017	Diabetes International Diabetes Federation (IDF) estimated 4.0 million deaths worldwide were directly or indirectly attributed to diabetes.
2017	Polycystic ovary syndrome Another review found that myo-inositol supplementation appears effective in improving several hormonal disturbances associated with Polycystic Ovary Syndrome (PCOS).
2017	Polycystic ovary syndrome Multiple reviews examined the potential of myo-inositol and D-chiro-inositols in regulating menstrual cycles and improving ovulation, concluding there is a lack of evidence regarding pregnancy probability.
2017	Hyperandrogenism A meta-analysis study was conducted demonstrating that bariatric surgery in women with severe obesity and PCOS can decrease total and free testosterone levels, and help correct hirsutism and menstrual dysfunction.
2016	Diabetes A systematic review found potential harm in treating blood pressure to targets lower than 140 mmHg for people with diabetes.
2016	Polycystic ovary syndrome The National Institute of Health allocated only 0.1% of its $32.3 billion research budget to PCOS research, highlighting the limited funding for this condition.
2015	Diabetes American Diabetes Association released recommendations for aspirin use in diabetes management, suggesting low-dose aspirin is reasonable for adults with diabetes at intermediate risk of cardiovascular disease (10-year risk between 5-10%).
2015	Diabetes American Diabetes Association recommends that people with diabetes and albuminuria should receive renin-angiotensin system inhibitors to reduce risks of end-stage renal disease, cardiovascular events, and death.
2015	Polycystic ovary syndrome A systematic review concluded there was no evidence that vitamin D supplementation reduced or mitigated metabolic and hormonal dysregulations in PCOS.
2014	Polycystic ovary syndrome A medical review concluded that the use of metformin during the first trimester does not increase the risk of major birth defects in women with PCOS.
2013	Diabetes Global diabetes prevalence increased to 382 million people, a significant rise from 108 million in 1980.
2013	Polycystic ovary syndrome A scientific review found similar improvements in multiple health metrics for women with PCOS through weight loss, regardless of diet composition.
2013	Polycystic ovary syndrome A scientific review found similar improvements in various health parameters for women with PCOS through weight loss, independent of specific diet composition.
2012	Polycystic ovary syndrome A review was published finding that myo-inositol supplementation appears to be effective in improving several hormonal disturbances associated with Polycystic Ovary Syndrome (PCOS).
2012	Diabetes World Health Organization (WHO) estimates diabetes resulted in 1.5 million deaths, ranking it as the 8th leading cause of death globally.
2012	Polycystic ovary syndrome A review found that myo-inositol supplementation appears to be effective in improving several hormonal disturbances associated with PCOS.
2011	Polycystic ovary syndrome A review was conducted finding insufficient evidence to conclude any beneficial effect from D-chiro-inositol for PCOS management.
2011	Hyperandrogenism The International Association of Athletics Federations (now World Athletics) and IOC (International Olympic Committee) released statements restricting the eligibility of female athletes with high testosterone, introducing hyperandrogenism regulations that impacted athletes with differences in sex development.
2010	Polycystic ovary syndrome A medical review was published concluding that women with Polycystic Ovary Syndrome (PCOS) have an elevated prevalence of insulin resistance and type 2 diabetes, independent of body mass index (BMI).
2010	Diabetes US diabetes-related emergency room visit rates revealed significant economic disparities, with lowest income communities experiencing 526 per 10,000 population visits, compared to 236 per 10,000 in highest income communities. Approximately 9.4% of these ER visits were for uninsured individuals.
2010	Diabetes Analysis of diabetes-related emergency room visits in the United States revealed stark socioeconomic disparities, with lower-income communities experiencing significantly higher ER visit rates (526 per 10,000 population) compared to high-income communities (236 per 10,000 population).
2010	Polycystic ovary syndrome A study of 596 women with PCOS used liquid chromatography–mass spectrometry (LC–MS) to precisely quantify testosterone levels, revealing median testosterone values of 41 and 47 ng/dL across two different laboratories.

This contents of the box above is based on material from the Wikipedia articles Hyperandrogenism, Diabetes & Polycystic ovary syndrome, which are released under the Creative Commons Attribution-ShareAlike 4.0 International License.